Triple

T187828
Position Surface form Disambiguated ID Type / Status
Subject Children's Hospital of Philadelphia E4020 entity
Predicate hasResearchCenter P40 FINISHED
Object Center for Applied Genomics
The Center for Applied Genomics is a major pediatric genomics research institute specializing in identifying genetic factors underlying childhood diseases and advancing precision medicine.
E23964 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Applied Genomics | Statement: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Applied Genomics]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Center for Applied Genomics
Context triple: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Applied Genomics]
  • A. National Human Genome Research Institute
    The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
  • B. Broad Institute of MIT and Harvard
    The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. Center for Cancer Research
    The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
  • E. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Center for Applied Genomics
Triple: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Applied Genomics]
Generated description
The Center for Applied Genomics is a major pediatric genomics research institute specializing in identifying genetic factors underlying childhood diseases and advancing precision medicine.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Center for Applied Genomics
Target entity description: The Center for Applied Genomics is a major pediatric genomics research institute specializing in identifying genetic factors underlying childhood diseases and advancing precision medicine.
  • A. National Human Genome Research Institute
    The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
  • B. Broad Institute of MIT and Harvard
    The Broad Institute of MIT and Harvard is a leading biomedical and genomic research center known for large-scale collaborative projects that advance understanding of human disease and inform new therapies.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. Center for Cancer Research
    The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
  • E. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a25497e2f08190a040f8c6e1842643 completed Feb. 28, 2026, 2:36 a.m.
NER Named-entity recognition batch_69a2594940e48190a3d8efbce46241c3 completed Feb. 28, 2026, 2:56 a.m.
NED1 Entity disambiguation (via context triple) batch_69a305e511a08190a560125ed3839a0c completed Feb. 28, 2026, 3:12 p.m.
NEDg Description generation batch_69a30679b0648190975dcfaf4f9846bf completed Feb. 28, 2026, 3:15 p.m.
NED2 Entity disambiguation (via description) batch_69a306e6ce6c8190a77d42643914b03a completed Feb. 28, 2026, 3:16 p.m.
Created at: Feb. 28, 2026, 2:40 a.m.